Skip to main content
  • NL
  • FR
  • EN
Other information and services: www.belgium.be
Logo of the Belgian Federal Authorities
Back to the homepage
  • Home
  • Decisions
  • Cartels
  • Abuses of dominant position
  • Mergers
  • DMA
  • Market test
  • About us
  • Contact
Menu
  1. Home
  2. About us
  3. Publications
  4. Current Page:Communication on information exchanges between pharmaceutical companies in the context of the reimbursement application procedure for combination therapies

Communication on information exchanges between pharmaceutical companies in the context of the reimbursement application procedure for combination therapies

Publication date
10 September 2025

Download(s)

  • 20250911_Communication_CombinationTherapies.pdf
  • Infographic_TC_EN.pdf
  • 20250911_Press_release_36_BCA.pdf

Recent decisions

26-RPR-04-AUD Newspaper distribution concession 2023-2027

12 February 2026
  • BMA-2026-RPR-4-AUD PUB.pdf
  • 20260213_Press_release_6_BCA.pdf
All decisions

About us

Contact us

Report a competition issue?

  • Home
  • Decisions
  • Cartels
  • Abuses of dominant position
  • Mergers
  • DMA
  • Market test
  • About us
  • Contact
  • Belgian Competition Authority
  • City Atrium, Vooruitgangstraat 50, 1210 Brussels
  • Route
  • +32 2 277 52 72
  • +32 2 277 53 23
  • info@bma-abc.be (link sends e-mail)

Share

Linkedin Share Button X Share Button Facebook Share Button

© Copyright 2015 - Belgian Competition Authority

  • Privacy
  • Terms of use
  • Cookie Policy